News

The Clinical Trials Environmental Impact Community of Interest (CoI) has been launched by The Pistoia Alliance, a global, non-profit alliance that promotes increased collaboration in life sciences R&D. Its goal is to calculate and compare the carbon footprints of...

The molecule tigilanol tiglate, also known as EBC-46, could provide tailored treatment for diseases including cancer, as according research from Stanford University in the US that was recently published in the scientific journal Nature Chemistry. The chemical is only naturally...

The Centre for Process Innovation (CPI) received a grant of £10.65 million to assist its work in the research, scale-up, and manufacture of RNA therapeutics as well as to finance the training centre already set up at the location,...

For years, global healthcare systems have been facing the triple threat of rising incidences of long-term conditions (LTC), aging populations and dwindling resources. At the same time, we have seen worldwide calls for affordable medicines – from the Jan...

The European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA) have collaborated on the Innovative Medicines Initiative (IMI), which has announced the commencement of the public-private research programme OPTIMA which is defined as Optimal Treatment for...

The global oral solid dosage (OSD) contract manufacturing market is anticipated to reach $54.7 billion in value by 2030, exhibiting a compound annual growth rate (CAGR) of 6%, according to a market analysis. As per data, oral solids are the...

Merck & Co. broke ground on a plant to produce next-generation inhalers on October 5th and rolled out a packaging facility in Singapore to serve its top-selling cancer medication and vaccine. The company's five-year investment plan for its Asia-Pacific regional...